2-chloro-1-fluoro-4-isothiocyanatobenzene

We are 2-chloro-1-fluoro-4-isothiocyanatobenzene CAS:137724-66-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-chloro-1-fluoro-4-isothiocyanatobenzene
CAS.NO:137724-66-4
Synonyms:2-chloro-1-fluoro-4-isothiocyanatobenzene
3-Chloro-4-fluorophenyl isothiocyanate
3-chloro-4-fluorobenzenisothiocyanate
2-chloro-1-fluoro-4-isothiocyanato-benzene
 
Physical and Chemical Properties:
Density 1.31g/cm3
Boiling Point 115-117 °C (11 mmHg)
Molecular Formula C7H3ClFNS
Molecular Weight 187.62200
Flash Point 130-132°C/15mm
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2-chloro-1-fluoro-4-isothiocyanatobenzene


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.2-Methoxyphenylboronic acid CAS:5720-06-9 There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.141-90-2 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.2-bromo-3-cloro-5-nitropiridina CAS:22353-41-9 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
2-(4-bromophenyl)triphenylene View Details
(Diacetoxyiodo)benzene View Details
2,2′-Anhydro-5-methyluridine View Details
4-(1-phenylethyl)benzene-1,3-diol manufacturer 2-Amino-4,6-Dimethoxy-1,3,5-Triazine manufacturer 2’-Deoxycytidine 5’-Triphosphate Disodium Salt manufacturer 4-(trifluoromethyl)-1H-indole manufacturer 2-Methyl-1-butanethiol manufacturer